Industry Advisory Board

The Industry Advisory Board (IAB) connects key leaders in the pharmaceutical and health care industry with talent and research in the WSU College of Pharmacy and Pharmaceutical Sciences (CPPS). Through networking opportunities and events with industry leaders, the IAB prepares graduate, Doctor of Pharmacy, and post doctoral students for future careers in drug development, translational research, and clinical practice. The IAB members are professionals in the pharmaceutical and health care industries who collaborate with the college, advise on academic programs, and help inform future research directions, as well as mentor individual students.


  • Advance collaborations among trainees, faculty, and IAB members, including developing new research directions.
  • Create opportunities for graduate, post doctoral, and Doctor of Pharmacy students to transition into leaders in their fields.
  • Ensure regular curricular updates in the graduate and Doctor of Pharmacy programs based on industry needs to maintain the highest academic quality.
  • Support the strategic plan and mission of the college.
  • Develop a highly skilled workforce to become the next generation of leaders of the pharmaceutical and health care industries.

Industry Members

Industry members comprise of scientists and business leaders from the following companies. Students interested in learning more about a specific company or field of interest are encouraged to contact Director of Industry Engagement Bhagwat Prasad for mentorship or internship opportunities.

  • AbbVie, Inc.
  • Alturas Analytics
  • Amgen
  • AstraZeneca
  • Bristol Myers Squibb
  • Boehringer Ingelheim
  • Charles River Labs
  • Chinook Therapeutics
  • Covance Inc
  • Daiichi Sankyo
  • Discovery Life Sciences
  • Genentech
  • Gilead Sciences
  • GIV-Gastrointestinal Vitality
  • Janssen Research & Development
  • Jubilant HollisterStier
  • Kaiser Permanente
  • KBP Biosciences
  • Lonza
  • Med-Aditus
  • Merck
  • Pfizer
  • Seagen
  • Solvo Biotechnology
  • Takeda
  • Terminal Phase Consultancy